BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 26845348)

  • 1. The epidemiology of the human papillomavirus related to oropharyngeal head and neck cancer.
    Gooi Z; Chan JY; Fakhry C
    Laryngoscope; 2016 Apr; 126(4):894-900. PubMed ID: 26845348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Human papilloma virus in head and neck cancer].
    Barry B; Ortholan C
    Cancer Radiother; 2014 Oct; 18(5-6):430-3. PubMed ID: 25151649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases.
    Berman TA; Schiller JT
    Cancer; 2017 Jun; 123(12):2219-2229. PubMed ID: 28346680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence trends in head and neck cancers and human papillomavirus (HPV)-associated oropharyngeal cancer in Canada, 1992-2009.
    Forte T; Niu J; Lockwood GA; Bryant HE
    Cancer Causes Control; 2012 Aug; 23(8):1343-8. PubMed ID: 22718355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The changing incidence of human papillomavirus-associated oropharyngeal cancer using multiple imputation from 2000 to 2010 at a Comprehensive Cancer Centre.
    Habbous S; Chu KP; Qiu X; La Delfa A; Harland LT; Fadhel E; Hui A; Perez-Ordonez B; Weinreb I; Liu FF; Waldron J; O'Sullivan B; Goldstein D; Xu W; Huang SH; Liu G
    Cancer Epidemiol; 2013 Dec; 37(6):820-9. PubMed ID: 24184275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer.
    Jain KS; Sikora AG; Baxi SS; Morris LG
    Cancer; 2013 May; 119(10):1832-7. PubMed ID: 23423883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low prevalence of human papillomavirus in oral cavity carcinomas.
    Machado J; Reis PP; Zhang T; Simpson C; Xu W; Perez-Ordonez B; Goldstein DP; Brown DH; Gilbert RW; Gullane PJ; Irish JC; Kamel-Reid S
    Head Neck Oncol; 2010 Mar; 2():6. PubMed ID: 20226055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Head and neck second primary cancer rates in the human papillomavirus era: A population-based analysis.
    Diaz DA; Reis IM; Weed DT; Elsayyad N; Samuels M; Abramowitz MC
    Head Neck; 2016 Apr; 38 Suppl 1():E873-83. PubMed ID: 25966421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Squamous cell carcinoma metastatic to neck from an unknown primary: the potential impact of modern pathologic evaluation on perceived incidence of human papillomavirus-positive oropharyngeal carcinoma prior to 1970.
    Chenevert J; Seethala RR; Barnes EL; Chiosea SI
    Laryngoscope; 2012 Apr; 122(4):793-6. PubMed ID: 22252715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus and diseases of the upper airway: head and neck cancer and respiratory papillomatosis.
    Gillison ML; Alemany L; Snijders PJ; Chaturvedi A; Steinberg BM; Schwartz S; Castellsagué X
    Vaccine; 2012 Nov; 30 Suppl 5():F34-54. PubMed ID: 23199965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of human papillomavirus-related head and neck cancer.
    Joseph AW; D'Souza G
    Otolaryngol Clin North Am; 2012 Aug; 45(4):739-64. PubMed ID: 22793850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD56-positive lymphocyte infiltration in relation to human papillomavirus association and prognostic significance in oropharyngeal squamous cell carcinoma.
    Wagner S; Wittekindt C; Reuschenbach M; Hennig B; Thevarajah M; Würdemann N; Prigge ES; von Knebel Doeberitz M; Dreyer T; Gattenlöhner S; Klussmann JP
    Int J Cancer; 2016 May; 138(9):2263-73. PubMed ID: 26662627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus (HPV) in head and neck cancer.
    Syrjänen S
    J Clin Virol; 2005 Mar; 32 Suppl 1():S59-66. PubMed ID: 15753013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in head and neck cancer incidence in Denmark, 1978-2007: focus on human papillomavirus associated sites.
    Blomberg M; Nielsen A; Munk C; Kjaer SK
    Int J Cancer; 2011 Aug; 129(3):733-41. PubMed ID: 20878955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The epidemiology of head and neck squamous cell carcinoma in The Netherlands during the era of HPV-related oropharyngeal squamous cell carcinoma. Is there really evidence for a change?
    van Monsjou HS; Schaapveld M; van den Brekel MW; Balm AJ
    Oral Oncol; 2015 Oct; 51(10):901-7. PubMed ID: 26216340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma Incidence, Vermont 1999-2013.
    Owosho AA; Wiley R; Stansbury T; Gbadamosi SO; Ryder JS
    J Community Health; 2018 Aug; 43(4):731-737. PubMed ID: 29427129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma.
    Ang KK; Sturgis EM
    Semin Radiat Oncol; 2012 Apr; 22(2):128-42. PubMed ID: 22385920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cavernous sinus involvement in human papillomavirus associated oropharyngeal squamous cell carcinoma: case report of an atypical site of distant metastasis.
    Forner D; Wilke D; Rigby MH; Croul S; Mishra A; Massoud E; Clarke DB; Lamond N
    J Otolaryngol Head Neck Surg; 2018 May; 47(1):32. PubMed ID: 29743120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPV positive oropharyngeal cancer and treatment deintensification: how pertinent is it?
    Laskar SG; Swain M
    J Cancer Res Ther; 2015; 11(1):6-9. PubMed ID: 25879328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anogenital HPV Infection as the Potential Risk Factor for Oropharyngeal Carcinoma].
    Sehnal B; Podlešák T; Kmoníčková E; Nipčová M; Driák D; Sláma J; Zikán M
    Klin Onkol; 2018; 31(2):103-109. PubMed ID: 29708352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.